Baricitinib (LY3009104, INCB028050)

Baricitinib (LY3009104, INCB028050)

Catalog Number:
L002369050APE
Mfr. No.:
APE-A4141
Price:
$277
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Baricitinib, formerly named LY3009104 or INCB028050, is a new selective orally bioavailable inhibitor of tyrosine-protein kinase JAK1 or JAK2. Also, it is an ATP competitive kinase inhibitor. In vitro, it is able to inhibit JAK1 and JAK2 in a low nanomolar range with IC50 values of 5.9 and 5.7 nM, respectively, while it demonstrates low inhibitory activity for JAK3 and moderate activity for TYK2. Baricitinib inhibits intracellular signaling of multiple proinflammatory cytokines including IL-6 and IL-23 at concentrations <50 nM. It should also be recognized that JAK signaling is central to a number of fundamental processes, including the generation of RBCs

      • Properties
        • Alternative Name
          INCB 028050,INCB-028050,LY 3009104,LY-3009104; 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
          CAS Number
          1187594-09-7
          Molecular Formula
          C16H17N7O2S
          Molecular Weight
          371.42
          Appearance
          A solid
          Purity
          98.24%
          Solubility
          insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Pin Li, Qin Li, et al. "LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy." EMBO Mol Med. 2022 Jan 11;14(1):e14511. PMID:34779136
          2. Yang L, Dong Y, et al. "IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer." Int J Cancer. 2019 Jan 22. PMID:30671927
          3. Choi J, Cooper ML, et al."Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease." Leukemia.2018 Apr 2. PMID:29691471

    We Also Recommend

    CYT387

    $220

    TG101209

    $220

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.